Exact Sciences Corporation stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Exact Sciences Corporation stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Exact Sciences Corporation do? Business model and key facts
Get the full picture of Exact Sciences Corporation: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Employees (FY): 6900
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Stocks related to Exact Sciences Corporation
Selected based on industry alignment and relative market positioning.
Events and news impacting Exact Sciences Corporation stock
Earnings, coporate decisions and industry developments that can affect the share price.
Exact Sciences Corporation fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
